Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale

Hendrée E. Jones, Carl Seashore, Elisabeth Johnson, Evette Horton, Kevin E. O'Grady, Kim Andringa, Matthew R. Grossman, Bonny Whalen, Alison Volpe Holmes

Research output: Contribution to journalArticle

Abstract

Background and Objectives: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; “Finnegan Scale”) and the MOTHER NAS Scale (MNS). Methods: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone. Results: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed.62 at first administration, peak NAS score, and NAS treatment initiation. Conclusions: Findings support the need for development of a NAS measure based on sound psychometric principles. Scientific Significance: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370–373).

Original languageEnglish (US)
Pages (from-to)370-373
Number of pages4
JournalAmerican Journal on Addictions
Volume25
Issue number5
DOIs
StatePublished - Aug 1 2016

Fingerprint

Psychometrics
Opioid Analgesics
Mothers
Neonatal Abstinence Syndrome
Research
Buprenorphine
Methadone
Pregnant Women
Therapeutics
Newborn Infant

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Jones, H. E., Seashore, C., Johnson, E., Horton, E., O'Grady, K. E., Andringa, K., ... Holmes, A. V. (2016). Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. American Journal on Addictions, 25(5), 370-373. https://doi.org/10.1111/ajad.12388

Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. / Jones, Hendrée E.; Seashore, Carl; Johnson, Elisabeth; Horton, Evette; O'Grady, Kevin E.; Andringa, Kim; Grossman, Matthew R.; Whalen, Bonny; Holmes, Alison Volpe.

In: American Journal on Addictions, Vol. 25, No. 5, 01.08.2016, p. 370-373.

Research output: Contribution to journalArticle

Jones, HE, Seashore, C, Johnson, E, Horton, E, O'Grady, KE, Andringa, K, Grossman, MR, Whalen, B & Holmes, AV 2016, 'Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale', American Journal on Addictions, vol. 25, no. 5, pp. 370-373. https://doi.org/10.1111/ajad.12388
Jones HE, Seashore C, Johnson E, Horton E, O'Grady KE, Andringa K et al. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. American Journal on Addictions. 2016 Aug 1;25(5):370-373. https://doi.org/10.1111/ajad.12388
Jones, Hendrée E. ; Seashore, Carl ; Johnson, Elisabeth ; Horton, Evette ; O'Grady, Kevin E. ; Andringa, Kim ; Grossman, Matthew R. ; Whalen, Bonny ; Holmes, Alison Volpe. / Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. In: American Journal on Addictions. 2016 ; Vol. 25, No. 5. pp. 370-373.
@article{2f7acbedc73d4e3ebe0432cda3c219cc,
title = "Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale",
abstract = "Background and Objectives: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; “Finnegan Scale”) and the MOTHER NAS Scale (MNS). Methods: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone. Results: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed.62 at first administration, peak NAS score, and NAS treatment initiation. Conclusions: Findings support the need for development of a NAS measure based on sound psychometric principles. Scientific Significance: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370–373).",
author = "Jones, {Hendr{\'e}e E.} and Carl Seashore and Elisabeth Johnson and Evette Horton and O'Grady, {Kevin E.} and Kim Andringa and Grossman, {Matthew R.} and Bonny Whalen and Holmes, {Alison Volpe}",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/ajad.12388",
language = "English (US)",
volume = "25",
pages = "370--373",
journal = "American Journal on Addictions",
issn = "1055-0496",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale

AU - Jones, Hendrée E.

AU - Seashore, Carl

AU - Johnson, Elisabeth

AU - Horton, Evette

AU - O'Grady, Kevin E.

AU - Andringa, Kim

AU - Grossman, Matthew R.

AU - Whalen, Bonny

AU - Holmes, Alison Volpe

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background and Objectives: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; “Finnegan Scale”) and the MOTHER NAS Scale (MNS). Methods: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone. Results: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed.62 at first administration, peak NAS score, and NAS treatment initiation. Conclusions: Findings support the need for development of a NAS measure based on sound psychometric principles. Scientific Significance: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370–373).

AB - Background and Objectives: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; “Finnegan Scale”) and the MOTHER NAS Scale (MNS). Methods: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone. Results: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed.62 at first administration, peak NAS score, and NAS treatment initiation. Conclusions: Findings support the need for development of a NAS measure based on sound psychometric principles. Scientific Significance: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370–373).

UR - http://www.scopus.com/inward/record.url?scp=84990183735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990183735&partnerID=8YFLogxK

U2 - 10.1111/ajad.12388

DO - 10.1111/ajad.12388

M3 - Article

C2 - 27287965

AN - SCOPUS:84990183735

VL - 25

SP - 370

EP - 373

JO - American Journal on Addictions

JF - American Journal on Addictions

SN - 1055-0496

IS - 5

ER -